APPLICATION
ANDA060272
TYPE
ANDA
ORIGINAL APPROVAL
1981-06-23
LATEST ACTION
1999-05-06
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Discontinued
Products
E-MYCINDiscontinued
ERYTHROMYCIN 250MG · TABLET, DELAYED RELEASE · ORAL
E-MYCINDiscontinued
ERYTHROMYCIN 333MG · TABLET, DELAYED RELEASE · ORAL
Approval history
1999-05-06Labeling · Supplement 34AP
1994-09-01Manufacturing (CMC) · Supplement 30AP
1994-09-01Labeling · Supplement 35AP
1993-11-03Manufacturing (CMC) · Supplement 37AP
1991-12-18Labeling · Supplement 10AP
1990-11-19Manufacturing (CMC) · Supplement 29AP
1989-03-01Manufacturing (CMC) · Supplement 28AP
1981-06-23OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.